Colorectal Cancer (CRC) Unknown Status Phase 2 Trials for Fluorouracil (DB00544)

Back to Colorectal Cancer (CRC)

Also known as: Malignant Neoplasm of Colorectum / CRC, Colorectal Cancer / Colorectal Cancer / Cancer, Colorectal / CRC (Colorectal Cancer) / Colorectal, Cancer / Colo-rectal Cancer / Colorectal Cancers / A. Colorectal Cancer / Cancer Colorectal / Gastrointestinal Cancers - Colorectal / CRC / CRCS / Malignant colorectal neoplasm / Malignant neoplasm of cecum and/or colon and/or rectum / Malignant neoplasm of caecum and/or colon and/or rectum / Malignant neoplasm of cecum and/or colon and/or rectum (disorder) / Malignant neoplasm of large intestine / Malignant tumor of large intestine / Malignant tumour of large intestine / Malignant neoplasm of large intestine (disorder) / Malignant neoplasm of colon, unspecified / Malignant large intestinal neoplasm NOS / Cancer of large intestine / Malignant neoplasm of large intestine, NOS / Cancer of large bowel / CA - Cancer of large bowel / Colorectal neoplasms malignant / Malignant neoplasm of colon and/or rectum (disorder) / Large intestine carcinoma / Colorectal carcinoma / Colorectal cancer NOS

Indication	Status	Phase
DBCOND0031867 (Colorectal Cancer (CRC))	Unknown Status	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT05480280	mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer	Treatment	Dalpiciclib (DB17456) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT04734249	Second-line Surufatinib Combined With Chemotherapy in Advanced CRC	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Surufatinib (DB15106)
NCT02071069	Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer	Treatment	Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762)
NCT06120127	Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526) Sintilimab (DB15765)
NCT05839470	Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer	Treatment	Bevacizumab (DB00112) Cadonilimab (DB16680) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT01515787	PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT05871333	Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients	Prevention	Fluorouracil (DB00544) Leucovorin (DB00650) Losartan (DB00678) Oxaliplatin (DB00526)
NCT00072553	Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer	Treatment	Celecoxib (DB00482) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT01802645	Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT06003998	Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab	Treatment	Bevacizumab (DB00112) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT05684211	A Study of Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal Cancer	Treatment	Ametumumab (DB27640) Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Toripalimab (DB15043)
NCT06010888	Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRC	Treatment	Fluorouracil (DB00544) Fruquintinib (DB11679) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00006115	Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT01193452	S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650)
NCT05200299	mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT02415699	DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT02978313	Cetuximab Monotherapy Maintenance Treatment in mCRC	Treatment	Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650)
NCT05842525	Fruquintinib Plus FOLFIRI in RAS-mutated Metastatic Colorectal Cancer	Treatment	Fluorouracil (DB00544) Fruquintinib (DB11679) Irinotecan (DB00762) Leucovorin (DB00650)
NCT00513266	Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT05340231	An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT04668976	A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma	Treatment	Cetuximab (DB00002) Floxuridine (DB00322) Fluorouracil (DB00544) Gemcitabine (DB00441) Irinotecan (DB00762) Oxaliplatin (DB00526) Panitumumab (DB01269)
NCT01196260	Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Oxaliplatin (DB00526)
NCT03711240	The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases	Treatment	Bevacizumab (DB00112) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00884767	Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00274872	Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT01529164	Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer	Treatment	Endostatin (DB06423) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00027833	Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer	Treatment	Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650)
NCT00408551	Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver	Treatment	Floxuridine (DB00322) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT05511051	A Prospective Multi-centered Randomized Controlled Trial on Fruquintinib in Combination With HAIC in the Treatment of Liver Metastatic Colorectal Cancer After Failure of Second-line Systematic Therapy	Treatment	Fluorouracil (DB00544) Fruquintinib (DB11679) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00544011	Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Treatment	Bevacizumab (DB00112) Capecitabine (DB01101) Fluorouracil (DB00544) Irinotecan (DB00762)
NCT01628211	Second Look Laparoscopy in Colorectal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT00438737	Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT02942706	Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC	Treatment	Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT02515734	A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab	Treatment	Bevacizumab (DB00112) Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)
NCT03727763	Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT)	Treatment	Cetuximab (DB00002) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Vemurafenib (DB08881)
NCT00647530	Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Oxaliplatin (DB00526) Panitumumab (DB01269)
NCT01736904	wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650)
NCT00006112	Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Mitomycin (DB00305)
NCT00075595	Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer	Treatment	Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650)
NCT05524155	Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis	Treatment	Fluorouracil (DB00544) Leucovorin (DB00650) Oxaliplatin (DB00526) Regorafenib (DB08896) Sintilimab (DB15765)
NCT02688023	Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer	Treatment	Capecitabine (DB01101) Fluorouracil (DB00544) Irinotecan (DB00762) Leucovorin (DB00650) Oxaliplatin (DB00526)